Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...

The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first treatment for acute hepatitis C virus ...

Fluctuations in circulating hepatitis C virus RNA could be "clinically meaningful" in a substantial number of patients with chronic infection, and could influence the best time to prescribe antiviral ...

In 2005, Nick Voyles was diagnosed with hepatitis C after being released from five years of incarceration. A nurse told him he had only six months to live. He was prescribed a drug cocktail, a ...

The fight against viral hepatitis has witnessed both remarkable triumphs and persistent challenges. As a doctor and researcher, I have witnessed firsthand how groundbreaking advancements in treatment ...

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis. Objectives: To estimate the ...

Viral hepatitis is an infection of the liver with one of five strains of the hepatitis virus (A, B, C, D, or E), resulting in liver inflammation and damage. Hepatitis ...

If you’ve heard of hepatitis C (hepa-what?!), you might think of actress Pamela Anderson, who was diagnosed with the disease in the early 2000s. Or maybe you associate it with people who have ...